Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments

Gesmar RS Segundo1, Fab&iacute;ola A Gomes2, Karla P Fernandes1, Ronaldo Alves3, Deise AO Silva3, Ernesto A Taketomi31Department of Pediatrics, 2Department of Nursery, 3Laboratory of Allergy and Clinical Immunology, Universidade Federal de Uberlandia, Uberlandia, BrazilBackground: Therapy fo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gesmar RS Segundo, Fab&iacute;ola A Gomes, Karla P Fernandes, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ee3131fdfb5a47f2a5b8a345742ecb8e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ee3131fdfb5a47f2a5b8a345742ecb8e
record_format	dspace
spelling	oai:doaj.org-article:ee3131fdfb5a47f2a5b8a345742ecb8e2021-12-02T04:33:47ZLocal cytokines and clinical symptoms in children with allergic rhinitis after different treatments1177-54751177-5491https://doaj.org/article/ee3131fdfb5a47f2a5b8a345742ecb8e2009-10-01T00:00:00Zhttp://www.dovepress.com/local-cytokines-and-clinical-symptoms-in-children-with-allergic-rhinit-a3595https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491Gesmar RS Segundo1, Fab&iacute;ola A Gomes2, Karla P Fernandes1, Ronaldo Alves3, Deise AO Silva3, Ernesto A Taketomi31Department of Pediatrics, 2Department of Nursery, 3Laboratory of Allergy and Clinical Immunology, Universidade Federal de Uberlandia, Uberlandia, BrazilBackground: Therapy for allergic rhinitis aims to control symptoms and improve the quality of life. The treatment of allergic rhinitis includes allergen avoidance, environmental controls, pharmacologic treatment, and specific immunotherapy.Objectives: The aim of this study is to evaluate the clinical changes and the levels of interferon-&gamma; (IFN-&gamma;) and interleukin-5 (IL-5) in nasal lavage fluid from children with allergic rhinitis after different types of pharmacologic treatment (mometasone, montelukast, or desloratadine).Methods: Twenty-four children aged from six to 12 years with moderate persistent allergic rhinitis were randomized into three groups receiving monotherapy treatment over four weeks: nasal corticosteroid (mometasone), leukotriene modifier (montelukast), or antihistamine (desloratadine). The perception of symptom improvement during the medication use was evaluated at the end of the treatment. Samples of nasal lavage fluid were collected before and after treatment for measuring IFN-&gamma; and IL-5 cytokines by ELISA.Results: All parents perceived an improvement in symptoms. Significant enhancement was seen in the mometasone group compared to those with montelukast (P = 0.01) and desloratadine (P = 0.02). No significant differences were found among the three groups in the levels of IL-5 and IFN-&gamma; in nasal fluid at baseline or after treatment. Only the group treated with mometasone showed a slight but significant reduction in IL-5 levels after the treatment period as compared with levels before the treatment (P = 0.0469).Conclusion: The group treated with mometasone showed better improvement of clinical symptoms and a slight reduction in IL-5 levels in the nasal fluid. This may indirectly reflect the relative immunomodulatory effects of the drugs tested.Keywords: allergic rhinitis, cytokines, IL-5, IFN-&gamma;, nasal fluid, desloratadine, mometasone, montelukast, allergy Gesmar RS SegundoFab&iacute;ola A GomesKarla P Fernandeset alDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2009, Iss default, Pp 469-474 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Gesmar RS Segundo Fab&iacute;ola A Gomes Karla P Fernandes et al Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
description	Gesmar RS Segundo1, Fab&iacute;ola A Gomes2, Karla P Fernandes1, Ronaldo Alves3, Deise AO Silva3, Ernesto A Taketomi31Department of Pediatrics, 2Department of Nursery, 3Laboratory of Allergy and Clinical Immunology, Universidade Federal de Uberlandia, Uberlandia, BrazilBackground: Therapy for allergic rhinitis aims to control symptoms and improve the quality of life. The treatment of allergic rhinitis includes allergen avoidance, environmental controls, pharmacologic treatment, and specific immunotherapy.Objectives: The aim of this study is to evaluate the clinical changes and the levels of interferon-&gamma; (IFN-&gamma;) and interleukin-5 (IL-5) in nasal lavage fluid from children with allergic rhinitis after different types of pharmacologic treatment (mometasone, montelukast, or desloratadine).Methods: Twenty-four children aged from six to 12 years with moderate persistent allergic rhinitis were randomized into three groups receiving monotherapy treatment over four weeks: nasal corticosteroid (mometasone), leukotriene modifier (montelukast), or antihistamine (desloratadine). The perception of symptom improvement during the medication use was evaluated at the end of the treatment. Samples of nasal lavage fluid were collected before and after treatment for measuring IFN-&gamma; and IL-5 cytokines by ELISA.Results: All parents perceived an improvement in symptoms. Significant enhancement was seen in the mometasone group compared to those with montelukast (P = 0.01) and desloratadine (P = 0.02). No significant differences were found among the three groups in the levels of IL-5 and IFN-&gamma; in nasal fluid at baseline or after treatment. Only the group treated with mometasone showed a slight but significant reduction in IL-5 levels after the treatment period as compared with levels before the treatment (P = 0.0469).Conclusion: The group treated with mometasone showed better improvement of clinical symptoms and a slight reduction in IL-5 levels in the nasal fluid. This may indirectly reflect the relative immunomodulatory effects of the drugs tested.Keywords: allergic rhinitis, cytokines, IL-5, IFN-&gamma;, nasal fluid, desloratadine, mometasone, montelukast, allergy
format	article
author	Gesmar RS Segundo Fab&iacute;ola A Gomes Karla P Fernandes et al
author_facet	Gesmar RS Segundo Fab&iacute;ola A Gomes Karla P Fernandes et al
author_sort	Gesmar RS Segundo
title	Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
title_short	Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
title_full	Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
title_fullStr	Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
title_full_unstemmed	Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
title_sort	local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
publisher	Dove Medical Press
publishDate	2009
url	https://doaj.org/article/ee3131fdfb5a47f2a5b8a345742ecb8e
work_keys_str_mv	AT gesmarrssegundo localcytokinesandclinicalsymptomsinchildrenwithallergicrhinitisafterdifferenttreatments AT fabampiacuteolaagomes localcytokinesandclinicalsymptomsinchildrenwithallergicrhinitisafterdifferenttreatments AT karlapfernandes localcytokinesandclinicalsymptomsinchildrenwithallergicrhinitisafterdifferenttreatments AT etal localcytokinesandclinicalsymptomsinchildrenwithallergicrhinitisafterdifferenttreatments
_version_	1718401161363456000

Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments

Ejemplares similares